228 related articles for article (PubMed ID: 32745996)
21. Paraneoplastic neuromyelitis optica spectrum disorder: A case report and review of the literature.
Annus Á; Bencsik K; Obál I; Kincses ZT; Tiszlavicz L; Höftberger R; Vécsei L
J Clin Neurosci; 2018 Feb; 48():7-10. PubMed ID: 29133107
[TBL] [Abstract][Full Text] [Related]
22. Pediatric paraneoplastic neuromyelitis optica spectrum disorder associated with ovarian teratoma.
Tardo L; Wang C; Rajaram V; Greenberg BM
Mult Scler; 2022 Jan; 28(1):160-163. PubMed ID: 34423664
[TBL] [Abstract][Full Text] [Related]
23. Acute anosmia in neuromyelitis optica spectrum disorder.
Marshall J; Kleerekooper I; Davagnanam I; Trip SA
Mult Scler; 2020 Dec; 26(14):1958-1960. PubMed ID: 32228206
[TBL] [Abstract][Full Text] [Related]
24. [Characteristics of neuromyelitis optica spectrum disorder associated with the area postrema].
You XF; Hu HT; Ye J
Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(9):668-672. PubMed ID: 29534401
[No Abstract] [Full Text] [Related]
25. Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.
Rosales D; Kister I
Curr Allergy Asthma Rep; 2016 Jun; 16(6):42. PubMed ID: 27167974
[TBL] [Abstract][Full Text] [Related]
26. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
27. [A case report of neuromyelitis optica spectrum disorder with lesions of the medulla oblongata].
Sokhor NR; Yasniy OR
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):121-125. PubMed ID: 35394731
[TBL] [Abstract][Full Text] [Related]
28. Area postrema syndrome: An unusual presentation of neuromyelitis optica spectrum disorder.
Raj A; Valappil AV; Alapatt PJ; Kamar J
J Neurosci Rural Pract; 2023; 14(2):361-362. PubMed ID: 37181170
[TBL] [Abstract][Full Text] [Related]
29. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
30. Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder associated with esophageal cancer.
Kon T; Ueno T; Suzuki C; Nunomura J; Igarashi S; Sato T; Tomiyama M
J Neuroimmunol; 2017 Aug; 309():38-40. PubMed ID: 28601284
[TBL] [Abstract][Full Text] [Related]
31. Acute intractable vomiting: Do I belong somewhere else?
Anand S; Rai AS; Chhirolya R; Paliwal VK
Indian J Gastroenterol; 2018 Jul; 37(4):365-369. PubMed ID: 30088219
[TBL] [Abstract][Full Text] [Related]
32. [The role of aquaporin 4 antibody in the injury of retinal microstructure in neuromyelitis optica spectrum disorders].
Wang ZW; Wang QQ; Diao DW; Guo QF; Qi XK
Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):435-439. PubMed ID: 29925129
[No Abstract] [Full Text] [Related]
33. Hiccups, severe vomiting and longitudinally extensive transverse myelitis in a patient with prostatic adenocarcinoma and Aquaporin-4 antibodies.
Dinoto A; Bosco A; Sartori A; Bratina A; Bellavita G; Pasquin F; Cheli M; Manganotti P
J Neuroimmunol; 2021 Mar; 352():577488. PubMed ID: 33498007
[TBL] [Abstract][Full Text] [Related]
34. Neuromyelitis Optica Spectrum Disorder with Recurrent Intracranial Hemorrhage.
Yaguchi H; Mito Y; Ohashi I; Nomura T; Yabe I; Tajima Y
Intern Med; 2017; 56(13):1729-1732. PubMed ID: 28674367
[TBL] [Abstract][Full Text] [Related]
35. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood].
Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886
[No Abstract] [Full Text] [Related]
36. Paraneoplastic neuromyelitis optica spectrum disorders: a case series.
Virgilio E; Vecchio D; Vercellino M; Naldi P; Tesser F; Cantello R; Cavalla P; Comi C
Neurol Sci; 2021 Jun; 42(6):2519-2522. PubMed ID: 33506301
[TBL] [Abstract][Full Text] [Related]
37. A case of seropositive Neuromyelitis Optica in a paediatric patient with co-existing acute nephrotic syndrome.
Volkman T; Hemingway C
Mult Scler Relat Disord; 2017 Nov; 18():103-105. PubMed ID: 29141789
[TBL] [Abstract][Full Text] [Related]
38. Validation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of South Indian patients.
Kanikannan MA; Arepareddy PK; Mathukumalli NL; Y S; Kandadai RM; Jabeen AS; T S; Borgohain R
Mult Scler Relat Disord; 2019 Oct; 35():164-169. PubMed ID: 31382202
[TBL] [Abstract][Full Text] [Related]
39. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Sato DK; Nakashima I; Takahashi T; Misu T; Waters P; Kuroda H; Nishiyama S; Suzuki C; Takai Y; Fujihara K; Itoyama Y; Aoki M
Neurology; 2013 Jun; 80(24):2210-6. PubMed ID: 23677744
[TBL] [Abstract][Full Text] [Related]
40. Aquaporin 4-positive neuromyelitis optica spectrum disorder with meningoencephalitis-like onset: A case report.
Bu Y; Liu H; Qian X; Sun F; Li C; Han J
Front Immunol; 2022; 13():938492. PubMed ID: 36275714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
